As the expressions of Fzd9 and Fzd10 were evidently upregulated in pulmonary fibrogenesis, it is plausible to assume that Wnt7b/10a and Fzd9/10 could be the potential targets in IPF therapy. This evidence concerns the gene WNT7B and idiopathic pulmonary fibrosis.